Interim findings from a mixed-methods, multi-site study Joseph Lanario 1 , Nicola Anderson 1 , Olalekan Lee Aiyegbusi 1 , Ameeta Retzer 1 , Foram Khatsuria 1 , Nancy Bhardwaj 1 , Sarah Hughes 1 , Christel McMullan 1 , Flic Gaete Carvajal 1 , Philip Collis 1 , Roger Wilson 1 , Kamil Sterniczuk 1 , Yvonne Yalder 1 , Sarah Markham 1 , Emily Lam 1 , Clarice McKay 1 , Ian Clarke 1 , Robert Michell 1 , John Rose 1 , Samantha Drewett 1 , Melanie Calvert 1 1 University of Birmingham, Birmingham, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :210.3 Aims Patient-Reported Outcomes (PROs) can provide valuable insights into the impact of disease and treatment from the patient perspective
Remove the ice, wipe with alcohol, let the alcohol dry, then inject
If ongoing maintenance is necessary: Year 2: Compounded $2,388 vs Brand-name $11,628 (savings: $9,240) Year 3: Compounded $2,388 vs Brand-name $11,628 (savings: $9,240) Year 4: Compounded $2,388 vs Brand-name $11,628 (savings: $9,240) Year 5: Compounded $2,388 vs Brand-name $11,628 (savings: $9,240) 5-year total: Compounded $11,940 vs Brand-name $58,140 (savings: $46,200) For people requiring truly long-term treatment, the cumulative savings from compounded alternatives make ongoing medication financially feasible where brand-name costs would be prohibitive
An FDA-approved appetite suppressant available as an affordable generic, prescribed at PEAK as part of a clinician-managed weight loss program
The inability to stop eating kind of takes over your life, says Joanne Dushay, M.D., an endocrinologist at Beth Israel Deaconess/Harvard who specializes in obesity medicine
These medicines can work effectively if you combine them with a proper diet and exercises to help control your blood sugar level